Merrill Downgrades Ivax Shares

Analyst Gregory Gilbert says the company missed his third-quarter estimates for sales, gross margin, and earnings per share

Ivax (IVX ) posted lower-than-expected third-quarter earnings per share of 17 cents. Merrill Lynch downgraded the shares to neutral from buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.